NY49149Jan. 29, 2013 - Kenneth Cole New York, through its licensee partner, the Geneva Watch Group, unveils the limited edition Powered by You watch, the newest style in its renowned automatic watch collection. The limited edition Powered by You watch is designed to inspire individuals to generate change in their global community. Through its partnership with Kenneth Cole New York and a continuation of both companies' long standing commitment to giving back, Geneva Watch Group will donate at least $25,000 from the sale of the watches to amfAR, the Foundation for AIDS Research.

Over 25 years ago, when publicly mentioning AIDS was still considered taboo, Kenneth Cole used his platform as a fashion designer to launch a series of provocative advertising campaigns that helped generate awareness and raise funds for research aimed at finding a cure. In 2011, Cole partnered with amfAR and the MTV Staying Alive Foundation on the reinterpretation of the iconic AIDS ribbon and created a celebrity driven international PSA campaign, re-igniting a new wave of awareness about the disease with the millennial generation. Now in his 8th year as Chairman of amfAR, Cole furthers his dedication to amfAR, an organization that has eased the burden of millions around the world living with AIDS. "This is the time to step up our investment in a cure for AIDS," says Kenneth Cole. "This new, limited edition Powered by You watch is intended to cultivate a call-to-action for today's generation to find a cure."

Check Out Our Latest Edition! 

rmcover vol59i1a


Latest New & Notable Products

rmnn vol58i6 mattel

rmnn vol58i6 holiday

Solution Providers
rmsolution v58i6

newswirelogo

  • NEW ORLEANS, Jan. 20, 2019 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until January 31, 2019 to file lead plaintiff applications in a securities class action lawsuit against Snap Inc. (NYSE: SNAP), if they purchased the Company’s shares between March 2, 2017, and August 10, 2017, inclusive (the “Class Period”) or traceable to its March 2, 2017 Initial Public Offering.  This action is pending in the United States District Court for the Central District of California.

  • NEW YORK, Jan. 20, 2019 (GLOBE NEWSWIRE) -- The global semiconductor dielectric etching equipment market is expected to reach USD 9.5 billion by 2024, growing at a CAGR of 4.8% from 2018 to 2024. The key factors driving the growth of global SDEE market include; miniaturization of semiconductor circuits and increasing demand for compact, high performance, and energy efficient electronic devices. Growing adoption of fine-shaped field effect transistors (FET) and rising demand for smart electronic devices such as smart phones, digital cameras, netbooks, PCs, and tablets are further propelling the growth of the global SDEE market.

  • KEMP, Texas, Jan. 20, 2019 (GLOBE NEWSWIRE) -- Larson Electronics, a Texas-based company with over 40 years of experience spearheading the industrial lighting sector, announced the release of a hazardous location metal halide light fixture producing 34,000 lumens of light output in a flood pattern with the ability to illuminate around 18,000 square feet of area. This light is available in pendant, ceiling or wall mount configurations and is Class I, Division 2 and Class II, Division 1 rated.

  • HONOLULU, Jan. 20, 2019 (GLOBE NEWSWIRE) -- Telstra and Infinera today unveiled a major boost to Telstra’s network services for customers in Asia Pacific, with a significant increase in fibre capacity to its subsea infrastructure using Infinera’s Infinite Capacity Engine 4 (ICE4).

  • ALPHARETTA, Ga., Jan. 20, 2019 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing treatments that restore and preserve vision for people with serious eye diseases, announced today that data from MAGNOLIA, an extension study of PEACHTREE, its pivotal Phase 3 trial of XIPERE™ (formerly “suprachoroidal CLS-TA”) in patients with macular edema associated with non-infectious uveitis, was presented by Pauline Merrill, MD during the winter symposium of the American Uveitis Society in Park City, UT. Dr. Merrill is a Partner at Illinois Retina Associates and Section Director of Uveitis in the Department of Ophthalmology at Rush University Medical Center.

Contact Us

Retail Merchandiser Magazine
150 N. Michigan Ave., Suite 900
Chicago, IL 60601

  312.676.1100
  312.676.1101

Click here for a full list of contacts.

Latest Edition

Spread The Love

Back To Top